baber/WOPTO huggingface dataset:
Patent AU-2002313256-B2 (AU)
Title: Light-receiving or light-emitting device and its production method
Inventor: NAKATA JOSUKE
IPC: H01L31/042
Filed: 2002-06-21
Granted: 2006-07-06
Abstract: A light-receiving device incorporation particulate semiconductor devices (solar cells) having a light-to-electricity transducing function or a light-emitting device incorporating particulate semiconductor devices (light-emitting diodes) having an electricity-to-light transducing function. In a solar cell panel (30) shown, solar cells (3) are arrayed on the same plane in rows. Each row of solar cells (3) are parallel interconnected through positive electrode wires and negative electrode wires (31a,31b), and solar cells (3) of adjoining rows are interconnected in series through a connection part (31c). These solar cells (3) connected in parallel and in series are covered with a transparent covering member, thus forming a panel. These solar cells (3) each have externally exposed positive and negative electrode terminals (34a,34b), and therefore the solar cells (3) can be interconnected in parallel, in series, or in parallel and series. When the conductive wires (31a,31b,31c) and the covering member are flexible, the device can be dormable. When the solar cells (3) are replaced with light-emitting diodes, the device can be a light-emitting one.
Patent AU-2002314215-B2 (AU)
Title: Enzymatic method of producing 4-0-beta-D galactopyranosyl-D-xylose, 4-0-beta-D-galactopyranosyl-D-xylose obtained using said method, compositions containing same and the use thereof in evaluating intestinal lactase
Inventor: REYES JUAN JOSE ARAGON
IPC: C12Q1/34
Filed: 2002-06-14
Granted: 2006-11-16
Abstract: In the preparation of 4-O-beta -D-galactopyranosyl-D-xylose (I) by reacting D-xylose, a beta -galactopyranoside substrate and beta -D-galactosidase (BDG) in aqueous buffer, (I) is isolated (after deactivating or removing the BDG and removing the substrate aglycone) by adding celite, carrying out solid-liquid extraction and eluting from a column, and (I)-containing fractions are treated by crystallization. Preparation of 4-O-beta -D-galactopyranosyl-D-xylose (I) involves: (i) treating a mixture of 2-20 wt.% D-xylose, 0.5-5 wt.% of a beta -galactopyranoside (as substrate) and 75-97.5 wt.% aqueous buffer of pH 5.0-9.0 (as reaction medium) with 10-1000 U (per g of substrate) of beta -D-galactosidase (BDG); (ii) carrying out disaccharide-forming reaction at a temperature between the freezing point of the mixture and 45[deg]C for 2-48 hours; (iii) deactivating the BDG by freezing at -20 to -170[deg]C or by heating at 95-115[deg]C or removing the BDG from the mixture by ultrafiltration; (iv) removing the aglycone of the substrate by extraction or filtration, and (v) isolating the (I)-containing fractions. Step (v) is carried out by adding celite, carrying out solid-liquid extraction with a solvent and eluting from a column with a first eluant, or by directly adding activated carbon, filtering and eluting with a second solvent. The (I)-containing fractions are further treated by crystallization from a mixture of acetone and methanol (or water) in a ratio of 5-20:1. An independent claim is included for (I) obtained by the process.
Patent AU-2002315414-B2 (AU)
Title: Water-soluble polymeric metal ion affinity compositions and methods for using the same
Inventor: TCHAGA GRIGORIY S
IPC: C08B37/12
Filed: 2002-06-20
Granted: 2008-02-07
Abstract: Water-soluble metal ion affinity compounds and methods for using the same are provided. The subject compounds include an aspartate based metal chelating ligand bonded to a water-soluble polymeric substrate, where the ligand is complexed with a metal ion. In certain embodiments, the subject compounds further include a member of a signal producing system, e.g., a directly or an indirectly detectable label moiety. Also provided are water-insoluble supports having the subject compounds present on, e.g., immobilized on, at least one surface thereof. The subject compounds find use in a variety of different applications, including analyte detection and analyte purification applications.
Patent AU-2002339757-B2 (AU)
Title: Method for production of nitrate-containing products from undercooling melts
Inventor: MOLAND LARS
IPC: C05C5/00
Filed: 2002-11-01
Granted: 2008-10-02
Abstract: The invention concerns a method for the production of nitrate containing products (fertilizers, technical products) from undercooling melts, wherein a XN-water solution is evaporated up to a content of 50-99.8 weight % XN, where X is one or more selected from Ca, Mg, NH, Na and K, and N means nitrate. The preferred range of XN is 70-99.5 weight %. The melt is cooled down to and kept at a temperature at or below the crystallisation point and finely divided solid XN powder consisting of the equilibrium phases is added to the melt. Melt drops are then formed and allowed to cool and solidify during up to 70 seconds. It is preferred to use a cooling belt for solidification of the particles. The belt is cooled by air, water, oil or another medium.
Patent AU-2002344582-B2 (AU)
Title: Nonhuman model animal of systemic lupus erythematosus
Inventor: NAKAMURA AKIRA
IPC: C07K16/18
Filed: 2002-10-25
Granted: 2007-10-25
Abstract: The present invention is to provide a non-human animal model of systemic lupus erythematosus wherein generation of anti-double stranded DNA antibody and anti-single stranded antibody is induced, and that is made to spontaneously develop glomerulonephritis and arthritis, and a screening method for a therapeutic agent for systemic lupus erythematosus wherein the non-human animal model is used. Fc gamma RIIB deficient mouse that is not made to spontaneously develop autoimmune pathology although its autoantibody response is enhanced is backcrossed into C57BL/6J (B6) mouse for 12 generations to generate Fc gamma RIIB deficient B6 mouse, the Fc gamma RIIB deficient B6 male mouse is intercrossed with lpr/B6 female mouse, and thus obtained Fc gamma RIIB<+/->/lpr<+/-> mice were further crossed to generate a mouse model of systemic lupus erythematosus.
Patent AU-2002360044-B2 (AU)
Title: Adhesive label, resealable package and label web
Inventor: ANDERSSON THOMAS
IPC: G09F3/10
Filed: 2002-12-23
Granted: 2007-10-18
Abstract: The invention relates to an adhesive label, a resealable package provide with such a label and a label web. The package has an openable flap ( 14 ) defined by an arcuate indication ( 16 ). The label ( 12 ) is adhesively fixed to the package body for the purpose of resealably sealing the flap. The label has a top portion forming a gripping tab ( 20 ) and two leg portions ( 22 ) extending in a diverging manner from the gripping tab ( 20 ) and defining between them a central recess ( 23 ). The label is integrated with at least one projecting indicator portion ( 24 ) for each leg portion ( 22 ), which indicator portions are adapted to be separated from the label ( 12 ) when the package ( 10 ) is opened for the first time. The leg portions with the projecting indicator portions ( 24 ) form a first contour on the convex side of the indication ( 16 ) and the leg portions ( 22 ) form a second contour on the concave side of the indication ( 16 ), which is complementary to the first contour. The web comprises a carrier for labels arranged in such a manner that a first contour of a label is fitted in and partially enclosed by a second contour of an adjoining label.
Patent AU-2003266799-B2 (AU)
Title: Alkyd-lactone copolymers for medical applications
Inventor: NATHAN ARUNA
IPC: A61L27/18
Filed: 2003-12-09
Granted: 2009-12-10
Abstract: The present invention is directed to biodegradable, biocompatible polymers that are the reaction product of a polybasic acid or derivative thereof, a monoglyceride and a lactone monomer, as well as medical devices and compositions containing such polymers.
Patent AU-2004201932-B2 (AU)
Title: Cleaning device for a bundle of tubular filter elements designed with one end open, preferably of an industrial dust filter
Inventor: KRAEBS RAINER
IPC: B01D46/04
Filed: 2004-05-06
Granted: 2009-07-16
Abstract: The cleaning system for a bundle of tubular filters, open at one end, has injectors (6) facing the filter openings to deliver bursts of compressed air into them. The compressed air supply is controlled by valves (14) into jet tubes (10-12) fitted with the injectors in rows. Only a section of each jet tube is connected to its valve, leading to a U-shaped deflection (20,21a,21b) into a second section in the reverse direction with a closed end (22).
Patent AU-2004260606-B2 (AU)
Title: Use of angiotensin II receptor antagonists, especially telmisartan, in order to increase insulin sensitivity
Inventor: UNGER THOMAS
IPC: A61K45/06
Filed: 2004-07-24
Granted: 2010-12-09
Abstract: Angiotensin II receptor antagonist is used to prepare a medicament for treating people for whom type 2 diabetes has been diagnosed or prediabetes is suspected, for preventing diabetes or for treating metabolic syndrome and insulin resistance in patients with normal blood pressure. An independent claim is also included for a composition comprising telmisartan in combination with: amlodipine or nifedipine; eplerenone or spironolactone; simvastatin or atorvastatin; rosiglitazone, pioglitazone, repaglinide or metformin; dipyridamol or clopidogrel, optionally in combination with aspirin; an aldosterone antagonist; a HMG-CoA reductase inhibitor; a dipeptidyl peptidase 4 inhibitor; a sulfonylurea; or a thrombocyte aggregation inhibitor. ACTIVITY : Antidiabetic. MECHANISM OF ACTION : Angiotensin II Receptor Antagonist; Peroxisomal Proliferator Activated Receptor Gamma (PPARgamma) Activator. PC12W cells overexpressing PPARgamma 2 and its heterodimer partner RXRalpha were treated with telmisartan (10 MicroM). PPARgamma activity was increased by a factor of 1.9.
Patent AU-2005215376-B2 (AU)
Title: Dopamine-agonist combination therapy with sedatives for improving sleep quality
Inventor: BARBERICH TIMOTHY J
IPC: A61K45/06
Filed: 2005-02-07
Granted: 2011-01-20
Abstract: The present invention generally relates to pharmaceutical compositions comprising a dopamine agonist and sedative agent. In a preferred embodiment, the dopamine agonist is optically pure (S)-didesmethylsibutramine. In a preferred embodiment, the sedative agent is optically pure (S)-zopiclone or optically pure (S)—N-desmethylzopiclone. In a preferred embodiment, the dopamine agonist is optically pure (S)-didesmethylsibutramine; and the sedative agent is optically pure (S)-zopiclone or optically pure (S)—N-desmethylzopiclone. The pharmaceutical compositions of the invention are useful in the treatment of restless-leg syndrome and periodic-limb-movement disorder, as well as various sleep disorders. In addition, the present invention relates to a method of treating a patient suffering from restless-leg syndrome, periodic-limb-movement disorder, a sleep abnormality, or insomnia, comprising coadministering a therapeutically effective amount of a dopamine agonist and a therapeutically effective amount of a sedative agent. In a preferred embodiment, the dopamine agonist is optically pure (S)-didesmethylsibutramine. In a preferred embodiment, the sedative agent is optically pure (S)-zopiclone or optically pure (S)—N-desmethylzopiclone. In a preferred embodiment, the dopamine agonist is optically pure (S)-didesmethylsibutramine; and the sedative agent is optically pure (S)-zopiclone or optically pure (S)—N-desmethylzopiclone.
Patent AU-2005232961-B2 (AU)
Title: Thio-substituted arylmethanesulfinyl derivatives
Inventor: LESUR BRIGITTE
IPC: C07D307/46
Filed: 2005-04-13
Granted: 2011-07-21
Abstract: The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions of compounds of Formula (A): wherein Ar, X, Y, R1, R2, R3, and q are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder ("ADHD"), enhancing function in disorders associated with hypofunctionality of the cerebral cortex, including, but not limited to, depression, schizophrenia, fatigue, in particular, fatigue associated with neurologic disease, such as multiple sclerosis, chronic fatigue syndrome, and improvement of cognitive dysfunction.
Patent AU-2005316586-B2 (AU)
Title: Impingement/ convection/ microwave oven and method
Inventor: WILLIAM DAY
IPC: A21B1/00
Filed: 2005-12-14
Granted: 2011-10-13
Abstract: A combination oven that is operable with convection air, impingement air and microwave energy in various combinations thereof. The oven has an oven chamber and a fan box that are located front to back. A fan in the fan box circulates heated air by discharging via openings in a top and a bottom and taking in via an intermediate opening of a baffle plate. Impingement plates are easily installed and removed in the oven chamber to provide impingement air upwardly or downwardly. At least one of the impingement plates is installed and removed by a sliding motion. Microwave energy is provided through the side walls of the oven chamber. Intake ports for cooling air are located in a bevel between the side walls and bottom wall of the oven's outer enclosure so as to allow the oven to be located right next to other structures, such as a wall. An interlock assembly is also provided for the oven door.
Patent AU-2006200332-B2 (AU)
Title: Bakeable, low-moisture, shelf-stable filler composition, savory food products, and processes for preparation
Inventor: FYFE KIM N
IPC: A23L27/00
Filed: 2006-01-25
Granted: 2012-05-24
Abstract: A savory, bakeable, shelf-stable, and low-moisture filler composition includes a) a dispersed fat phase comprising a triglyceride fat; b) an aqueous liquid phase comprising a polyol; and c) a solids phase comprising one of two savory filler components, wherein one filler component comprises cheese and the other filler component comprises a yeast extract. The filler composition has a water activity of about 0.25 to about 0.6. A savory food product may be made from the filler composition and a dough. The filler composition and dough may be extruded to form a food product such as a filled ball, a snack bar, a muesli bar, a nutritional bar, or a cold pressed bar. The savory food product has a water activity of about 0.25 to about 0.8.
Patent AU-2006200822-B2 (AU)
Title: Treatment of epithelial layer lesions
Inventor: THEODORE CORONEO MINAS
IPC: A61P15/02
Filed: 2006-02-27
Granted: 2011-07-21
Abstract: Abstract 5 Methods for the treatment of lesions originating in an epithelial layer, particularly diseases of the epithelium of the skin, bladder, oral mucosa, vagina and cervix are described. Also described are uses and formulations for the treatment of lesions originating in an epithelial layer.
Patent AU-2006220982-B2 (AU)
Title: Magnetic self-assembly for integrated circuit packages
Inventor: LIAN MING-REN
IPC: H01L23/32
Filed: 2006-02-28
Granted: 2010-11-11
Abstract: An integrated circuit package may include a substrate and an integrated circuit. The substrate may include at least one region, and a first magnetic material associated with the at least one region. The integrated circuit may have a second magnetic material associated therewith. The second magnetic material may be attracted to the first magnetic material to coupled the integrated circuit to the at least one region of the substrate. The IC package may be utilized in an RFID tag of an RFID system. An associated method for assembling an integrated circuit to a substrate is also provided.
Patent AU-2006222761-B2 (AU)
Title: Method of detecting connection of test port on an endoscope
Inventor: HAL WILLIAMS
IPC: A61L2/24
Filed: 2006-09-28
Granted: 2011-10-06
Abstract: - 25 A method detects proper connection of a test connection to an endoscope port which leads to an interior space beneath a flexible sheath on an endoscope. Both the 5 interior space and an air buffer are pressurized and then isolated from each other. Pressure in the interior space is vented and the isolation is removed. After the pressure settles out the new pressure is compared with the first pressure. If it has not dropped substantially it is determined that the test connection is not properly attached and the interior space is in fact not being pressurized. 27/09/06,16048 specification,25
Patent AU-2006235225-B2 (AU)
Title: Catalytic oxidation of hydrocarbon gas
Inventor: COVENTRY ANDREW
IPC: C01B32/50
Filed: 2006-04-18
Granted: 2012-01-19
Abstract: A process for the catalytic oxidation of a hydrocarbon gas comprising the steps of releasing pulses of a compressed hydrocarbon gas into an expansion chamber (8) and passing the expanded hydrocarbon gas over a catalytic converter (11) to oxidize the hydrocarbon gas.
Patent AU-2006321856-B2 (AU)
Title: Biocompatible surgical compositions
Inventor: NADYA BELCHEVA
IPC: C08G18/00
Filed: 2006-12-08
Granted: 2013-01-31
Abstract: Biocompatible compositions are provided including a first polymer component including an isocyanate-functional polyalkylene oxide combined with at least one multi-isocyanate functional polyether-polyurethane, and a second component including at least one diamine.
Patent AU-2006321913-B2 (AU)
Title: Biocompatible tissue sealants and adhesives
Inventor: BELCHEVA NADYA
IPC: A61K31/785
Filed: 2006-12-06
Granted: 2012-08-02
Abstract: The disclosure relates to compositions for medical/surgical synthetic adhesives and sealants. Adhesive compositions include a functionalized triol and functionalized diol, while sealant compositions further include a multifunctionalized polyol and at least one amine cross linker.
Patent AU-2007201762-B2 (AU)
Title: Container
Inventor: CASH WARREN
IPC: B65D21/024
Filed: 2007-04-20
Granted: 2013-04-18
Abstract: The present invention provides a container for storing and/or dispensing liquid including a body portion having a neck portion with an opening, at least one protrusion and at least one recessed portion whereby the container is adapted to utilise internal liquid pressure to provide strength for the container thus, requiring less material and avoiding the necessity for external packaging. 3r4 Figure 1
Patent AU-2007260887-B2 (AU)
Title: Edible pet chew and method of making the same
Inventor: BIERER TIFFANY
IPC: A23L29/20
Filed: 2007-06-21
Granted: 2013-07-18
Abstract: An edible pet chew is disclosed that is comprised of fibrous protein, water absorbing polymer, plasticizer and water. The pet chew provides excellent textural properties and improved solubility in the stomach and intestinal environment for improved pet safety.
Patent AU-2007268122-B2 (AU)
Title: System and method to display maintenance and operational instructions of an apparatus using augmented reality
Inventor: BAILLOT YOHAN
IPC: G06T19/00
Filed: 2007-05-10
Granted: 2012-04-26
Abstract: A head-mounted display provides a user with an augmented view of an object being viewed; a tracking mechanism such as a camera repeatedly determine the position and orientation of the head-mounted display relative the object being viewed; and a computer system provides information for the augmented view and repeatedly updates the augmented view of the object being viewed based on the determined position and orientation of the display. The head-mounted display may be a see-through display; it may be video-based or optical-based, and it may be monoscopic and stereoscopic. The tracking mechanism determines its position using one or more markers or beacons on the object being viewed. The markers may be active or passive, including light-emitting diodes (LEDs) that emit invisible light.
Patent AU-2007269361-B2 (AU)
Title: Seismic data processing
Inventor: VAN MANEN DIRK-JAN
IPC: G01V1/38
Filed: 2007-06-28
Granted: 2012-12-20
Abstract: Implementations of various technologies for processing seismic data. In one implementation, the seismic data may be processed by creating a fictitious source-receiver line connecting a source with a receiver location of interest, projecting one or more receiver locations adjacent the receiver location of interest onto the fictitious source-receiver line and decomposing seismic data on the receiver locations disposed on the fictitious source-receiver line into up-going wavefields and down-going wavefields.
Patent AU-2007313756-B2 (AU)
Title: Thin film apparatus and method
Inventor: KRAM BRIAN H
IPC: G01N1/31
Filed: 2007-10-29
Granted: 2012-08-16
Abstract: A platen for contacting a liquid to a surface of a substantially flat substrate is disclosed. The platen includes a liquid application station and a stripping element at an end of the liquid application station, wherein the stripping element includes an intersecting gap and an air barrier. Also disclosed are an apparatus including the platen and a method of using the platen to contact a substrate with a liquid.
Patent AU-2007320194-B2 (AU)
Title: Apparatus for sensing precipitation density of sludge in waste water treatment tank and method therefor
Inventor: HYEON WOOK
IPC: G01N31/00
Filed: 2007-11-13
Granted: 2013-08-29
Abstract: The present invention relates to an apparatus for sensing precipitation density of sludge in a wastewater treatment tank, more particularly to an apparatus and method for precisely taking density of sludge precipitated in a wastewater treatment tank without being contaminated by sludge. The present invention of an apparatus for sensing precipitation density of sludge in a waste water treatment tank comprises a container which is tube-shaped with a bottom thereof open and submerged in wastewater as filled with gas therein; and a sensor which is installed in the space in the container, and senses sludge density as not directly contacting with wastewater.
Patent AU-2007338135-B2 (AU)
Title: Multifilament, monofilament, non-woven or tape
Inventor: MULLER DANIEL
IPC: E01C13/08
Filed: 2007-12-17
Granted: 2012-10-25
Abstract: A multifilament, a monofilament, a non-woven or a tape, each having 1 to 2000 Denier per filament and a draw ratio of 1 :2 to 1 :11 and each made of a composition containing the components (A) a polyolefin, (B) for example a compound of the formula (B-1-a-1), (C) for example a compound of the formula (C-1-b-1), wherein b is a number from 2 to 20, and optionally (D) one or more inorganic and/or organic pigments.
Patent AU-2008254843-B2 (AU)
Title: Water resistant elasticized retention bandage and undercast liner
Inventor: EVANS JOHN C
IPC: A61F13/00
Filed: 2008-05-16
Granted: 2011-11-24
Abstract: A fabric substrate suitable for lining between a cast and a person. The fabric substrate includes a pair of opposing faces formed by pillar and inlay stitches. The fabric is constructed at least in part of hydrophobic, water-resistant yarns configured to provide enhanced water resistance and sufficient stretch in both a length and width direction to facilitate conforming the undercast liner around the anatomical shape without wrinkling during application. An intermediate tying layer spans between the opposing faces, and the tying layer includes elastic yarns stitched in a V stitch pattern such that the elastic yarns extend between one opposing fabric face and the other face.